Ann L. Jennerich

Ann L. Jennerich

Auto-generated profile, based on publicly available information

Ann L. Jennerich

Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine (W.A.K., E.K.K., J.T.N., L.P., A.L.J.), University of Washington, Seattle, Washington, USA; Cambia Palliative Care Center of Excellence (W.A.K., A.L.C., E.K.K., J.T.N., L.P., R.S., A.L.J.), University of Washington, Seattle, Washington, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
SEScott E. Evans
Scott E. Evans
AJAnn L. Jennerich
Ann L. Jennerich
Marwan M. AzarMarwan M. Azar
Marwan M. Azar
BCBin Cao
Bin Cao
KCKristina Crothers
Kristina Crothers
CCCharles S. Dela Cruz
Charles S. Dela Cruz
Background: This document provides evidence-based clinical practice guidelines on the diagnostic utility of nucleic acid–based testing of respiratory samples for viral pathogens other than influenza in adults with suspected community-acquired pneumonia (CAP). Methods: A multidisciplinary panel developed a Population–Intervention–Comparison–Outcome question, conducted a pragmatic systematic review, and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations. Results: The panel evaluated the literature to develop recommendations regarding whether routine diagnostics should include nucleic acid–based testing of respiratory samples for viral pathogens other than influenza in suspected CAP. The evidence addressing this topic was generally adjudicated to be of very low quality because of risk of bias and imprecision. Furthermore, there was little direct evidence supporting a role for routine nucleic acid–based testing of respiratory samples in improving critical outcomes such as overall survival or antibiotic use patterns. However, on the basis of direct and indirect evidence, recommendations were made for both outpatient and hospitalized patients with suspected CAP. Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was not addressed in the literature at the time of the evidence review. Conclusions: The panel formulated and provided their rationale for recommendations on nucleic acid–based diagnostics for viral pathogens other than influenza for patients with suspected CAP.

1 December 2015 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
ALAnn C. Long
Ann C. Long
SMSarah Muni
Sarah Muni
PTPatsy D. Treece
Patsy D. Treece
RERuth A. Engelberg
Ruth A. Engelberg
ENElizabeth L. Nielsen
Elizabeth L. Nielsen
JCJ. Randall Curtis
J. Randall Curtis
Background: Discussions about withdrawal of life-sustaining therapies often include family members of critically ill patients. These conversations should address essential components of the dying process, including expected time to death after withdrawal. Objectives: The study objective was to aid physician communication about the dying process by identifying predictors of time to death after terminal withdrawal of mechanical ventilation. Methods: We conducted an observational analysis from a single-center, before–after evaluation of an intervention to improve palliative care. We studied 330 patients who died after terminal withdrawal of mechanical ventilation. Predictors included patient demographics, laboratory, respiratory, and physiologic variables, and medication use. Results: The median time to death for the entire cohort was 0.58 hours (interquartile range (IQR) 0.22–2.25 hours) after withdrawal of mechanical ventilation. Using Cox regression, independent predictors of shorter time to death included higher positive end-expiratory pressure (per 1 cm H2O hazard ratio [HR], 1.07; 95% CI 1.04–1.11); higher static pressure (per 1 cm H2O HR, 1.03; 95% CI 1.01–1.04); extubation prior to death (HR, 1.41; 95% CI 1.06–1.86); and presence of diabetes (HR, 1.75; 95% CI 1.25–2.44). Higher noninvasive mean arterial pressure predicted longer time to death (per 1 mmHg HR, 0.98; 95% CI 0.97–0.99). Conclusions: Comorbid illness and key respiratory and physiologic parameters may inform physician predictions of time to death after withdrawal of mechanical ventilation. An understanding of the predictors of time to death may facilitate discussions with family members of dying patients and improve communication about end-of-life care.

1 October 2019 in Critical Care Medicine
Verified
Journal Article
Closed access
ALAnn C. Long
Ann C. Long
LBLyndia C. Brumback
Lyndia C. Brumback
JCJ. Randall Curtis
J. Randall Curtis
AAAlexander Avidan
Alexander Avidan
MBMario Baras
Mario Baras
CSCharles L. Sprung
Charles L. Sprung
Objectives: To develop an enhanced understanding of factors that influence providers’ views about end-of-life care, we examined the contributions of provider, hospital, and country to variability in agreement with consensus statements about end-of-life care. Design and Setting: Data were drawn from a survey of providers’ views on principles of end-of-life care obtained during the consensus process for the Worldwide End-of-Life Practice for Patients in ICUs study. Subjects: Participants in Worldwide End-of-Life Practice for Patients in ICUs included physicians, nurses, and other providers. Our sample included 1,068 providers from 178 hospitals and 31 countries. Interventions: None. Measurements and Main Results: We examined views on cardiopulmonary resuscitation and withholding/withdrawing life-sustaining treatments, using a three-level linear mixed model of responses from providers within hospitals within countries. Of 1,068 providers from 178 hospitals and 31 countries, 1% strongly disagreed, 7% disagreed, 11% were neutral, 44% agreed, and 36% strongly agreed with declining to offer cardiopulmonary resuscitation when not indicated. Of the total variability in those responses, 98%, 0%, and 2% were explained by differences among providers, hospitals, and countries, respectively. After accounting for provider characteristics and hospital size, the variance partition was similar. Results were similar for withholding/withdrawing life-sustaining treatments. Conclusions: Variability in agreement with consensus statements about end-of-life care is related primarily to differences among providers. Acknowledging the primary source of variability may facilitate efforts to achieve consensus and improve decision-making for critically ill patients and their family members at the end of life.

4 March 2014 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
ALAnn C. Long
Ann C. Long
RERuth A. Engelberg
Ruth A. Engelberg
LDLois Downey
Lois Downey
EKErin K. Kross
Erin K. Kross
LRLynn F. Reinke
Lynn F. Reinke
JCJ. Randall Curtis
J. Randall Curtis
Background: Minority race and lower socioeconomic status are associated with poorer patient ratings of health care quality and provider communication. Objective: To examine the association of race/ethnicity or socioeconomic status with patients' and families' ratings of end-of-life care and communication about end-of-life care provided by physicians-in-training. Methods: As a component of a randomized trial evaluating a program designed to improve clinician communication about end-of-life care, patients and patients' families completed preintervention survey data regarding care and communication provided by internal medicine residents and medical subspecialty fellows. We examined associations between patient and family race or socioeconomic status and ratings they gave trainees on two questionnaires: the Quality of End-of-Life Care (QEOLC) and Quality of Communication (QOC). Results: Patients from racial/ethnic minority groups, patients with lower income, and patients with lower educational attainment gave trainees higher ratings on the end-of-life care subscale of the QOC (QOCeol). In path models, patient educational attainment and income had a direct effect on outcomes, while race/ethnicity did not. Lower family educational attainment was also associated with higher trainee ratings on the QOCeol, while family non-white race was associated with lower trainee ratings on the QEOLC and general subscale of the QOC. Conclusions: Patient race is associated with perceptions of the quality of communication about end-of-life care provided by physicians-in-training, but the association was opposite to our hypothesis and appears to be mediated by socioeconomic status. Family member predictors of these perceptions differ from those observed for patients. Further investigation of these associations may guide interventions to improve care delivered to patients and families.

1 October 2020 in Chest
Verified
Journal Article
Closed access
AJAnn L. Jennerich
Ann L. Jennerich
MHMara R. Hobler
Mara R. Hobler
RSRashmi K. Sharma
Rashmi K. Sharma
RERuth A. Engelberg
Ruth A. Engelberg
JCJ. Randall Curtis
J. Randall Curtis

1 February 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
DHDon Hayes
Don Hayes
AJAnn L. Jennerich
Ann L. Jennerich
RCRyan D. Coleman
Ryan D. Coleman
EAEric Abston
Eric Abston
GAGregory T. Adamson
Gregory T. Adamson
DMDavid L. S. Morales
David L. S. Morales
Background: Pulmonary hypertension in children is progressive with wide variability in prognosis. This document provides an evidence-based clinical practice guideline for the management of children with progressive pulmonary hypertension despite optimal therapy. Methods: A multidisciplinary panel identified pertinent questions regarding the management of children with pulmonary hypertension that has progressed despite optimal therapy, conducted systematic reviews of the relevant literature, and applied the Grading of Recommendations, Assessment, Development and Evaluation approach to develop clinical recommendations. Results: After reviewing the research evidence, the panel considered the balance of desirable (benefits) and undesirable (harms and burdens) effects of the interventions in each proposed question. Valuation of our main outcomes was also considered, together with resources required, equity, acceptability, and feasibility. Recommendations were developed for or against interventional strategies specific to children with pulmonary hypertension that has progressed despite optimal therapy. Conclusions: Although there is a growing population of children with pulmonary hypertension, there is a striking lack of empirical evidence regarding management of those whose disease has progressed despite optimal pharmacotherapy. The panel formulated and provided the rationale for clinical recommendations for or against interventional strategies on the basis of this limited empirical evidence, coupled with expert opinion, to aid clinicians in the management of these complex pediatric patients. In addition, we identified important areas for future research.